Zurich Cantonal Bank
PTCT icon

Zurich Cantonal Bank’s PTC Therapeutics PTCT Stock Holding History

Zurich Cantonal Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Hold
26,965
– – ﹤0.01% 1086
2026
Q1 		$1.84M Buy
26,965
+4,133
+18% +$293K ﹤0.01% 1090
2025
Q4 		$1.73M Buy
22,832
+1,901
+9% +$138K ﹤0.01% 1023
2025
Q3 		$1.28M Sell
20,931
-9,681
-32% -$504K ﹤0.01% 1138
2025
Q2 		$1.5M Buy
30,612
+11,518
+60% +$547K ﹤0.01% 1023
2025
Q1 		$973K Buy
19,094
+231
+1% +$11.5K ﹤0.01% 1181
2024
Q4 		$851K Buy
18,863
+3,450
+22% +$148K ﹤0.01% 1287
2024
Q3 		$572K Buy
15,413
+884
+6% +$29.6K ﹤0.01% 1471
2024
Q2 		$444K Buy
14,529
+210
+1% +$6.8K ﹤0.01% 1564
2024
Q1 		$417K Buy
14,319
+854
+6% +$23.9K ﹤0.01% 1597
2023
Q4 		$371K Hold
13,465
– – ﹤0.01% 1702
2023
Q3 		$302K Buy
13,465
+1,509
+13% +$56.1K ﹤0.01% 1700
2023
Q2 		$486K Buy
11,956
+768
+7% +$37.6K ﹤0.01% 1368
2023
Q1 		$542K Buy
11,188
+713
+7% +$32.6K ﹤0.01% 1249
2022
Q4 		$400K Sell
10,475
-92
-0.9% -$3.83K ﹤0.01% 1387
2022
Q3 		$530K Buy
10,567
+1,126
+12% +$55.2K ﹤0.01% 1156
2022
Q2 		$378K Sell
9,441
-1,344
-12% -$47.1K ﹤0.01% 1400
2022
Q1 		$402K Buy
10,785
+785
+8% +$30.2K ﹤0.01% 1466
2021
Q4 		$398K Buy
10,000
+3,407
+52% +$130K ﹤0.01% 1631
2021
Q3 		$245K Hold
6,593
– – ﹤0.01% 1786
2021
Q2 		$279K Hold
6,593
– – ﹤0.01% 1591
2021
Q1 		$312K Sell
6,593
-1,351
-17% -$80.2K ﹤0.01% 1520
2020
Q4 		$485K Buy
7,944
+614
+8% +$36.2K ﹤0.01% 1307
2020
Q3 		$343K Hold
7,330
– – ﹤0.01% 1272
2020
Q2 		$372K Buy
7,330
+2,513
+52% +$123K ﹤0.01% 1164
2020
Q1 		$215K Buy
4,817
+1,221
+34% +$61.5K ﹤0.01% 1197
2019
Q4 		$173K Hold
3,596
– – ﹤0.01% 1416
2019
Q3 		$122K Buy
3,596
+474
+15% +$20.6K ﹤0.01% 1513
2019
Q2 		$140K Hold
3,122
– – ﹤0.01% 1434
2019
Q1 		$118K Buy
3,122
+390
+14% +$13.1K ﹤0.01% 1482
2018
Q4 		$94K Buy
2,732
+696
+34% +$25K ﹤0.01% 1635
2018
Q3 		$96K Buy
2,036
+666
+49% +$27.6K ﹤0.01% 1731
2018
Q2 		$46K Hold
1,370
– – ﹤0.01% 2182
2018
Q1 		$37K Hold
1,370
– – ﹤0.01% 2226
2017
Q4 		$23K Hold
1,370
– – ﹤0.01% 2365
2017
Q3 		$27K Buy
1,370
+696
+103% +$13.6K ﹤0.01% 2139
2017
Q2 		$12K Hold
674
– – ﹤0.01% 2392
2017
Q1 		$7K Hold
674
– – ﹤0.01% 2532
2016
Q4 		$7K Hold
674
– – ﹤0.01% 2501
2016
Q3 		$9K Hold
674
– – ﹤0.01% 2431
2016
Q2 		$5K Hold
674
– – ﹤0.01% 2494
2016
Q1 		$4K Hold
674
– – ﹤0.01% 2523
2015
Q4 		$22K Buy
674
+373
+124% +$11K ﹤0.01% 1988
2015
Q3 		$8K Buy
301
+206
+217% +$8.81K ﹤0.01% 2224
2015
Q2 		$5K Hold
95
– – ﹤0.01% 1935
2015
Q1 		$6K Buy
+95
New +$5.8K ﹤0.01% 1757

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Zurich Cantonal Bank's PTCT Position: Q2 2026 in Review

Zurich Cantonal Bank held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 26,965 shares worth $2.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1086.

Zurich Cantonal Bank first reported a position in PTCT in Q1 2015 and has held it in 46 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Zurich Cantonal Bank held 26,965 shares of PTC Therapeutics worth $2.2M as of Q2 2026.
  • Zurich Cantonal Bank left its PTC Therapeutics share count unchanged in Q2 2026.
  • PTC Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1086 holding.
  • Zurich Cantonal Bank first reported a position in PTC Therapeutics in Q1 2015 and has held it in 46 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.